$CRED
相关推文
按时间倒序
-
博主分享6只个股的短期交易策略，强调经验直觉胜过耐心口号。
最近 X 上流传着很多鼓舞人心的交易者心态，比如： “会有回报的。要有耐心。”全是废话。 交易者会考虑板块动量、催化剂、估值、回调、宏观、隐含波动率(IV)、期权流向等。 以下是我对各种股票短期交易的心态： 1. $NBIS - $111.91，尽管当天上涨了 1.53%，但由于 Meta 给予其 140 亿美元合同，CRWV 上涨了 12%。 这通常对所有新云厂商都是利好。它曾飙升至 $117（我可能仍会持有），但随后回落至 $111，可能是由于未平仓合约过多，但我们可能会继续看到上涨行情。因此我会利用这段时间进行定投(DCA)并买入看涨期权/股票，即使它已经上涨了 1.53%。 这不是“真正的下跌”，更像是上涨过程中的回调。 2. $HIMS - $56.4 下跌 4.67%，通常人们只是盲目抄底，但这实际上是由重大因素引起的，即特朗普推出了面向消费者的政府药品网站。随着股价升至 $60，空头比率降至 33%。 这次下跌可能会被用于空头回补。我在 $46 支撑位买入，但在反弹后不久卖出，因为我感觉它还会进一步下跌。但我个人更喜欢底部入场点，所以可能更接近 $50。 我记得 AMZN 推出竞争对手时，HIMS 暴跌 20% 然后再次上涨，我预计特朗普的计划中期也会如此，但近期它是一个逆风因素。 3. $RDDT - $228，下跌 5.45%，没有新闻。可能只是估值担忧。我们看到类似的增长股如 ALAB、CRED 有随机的 20% 回调。许多软件/社交股票如 SNAP 因非重大新闻下跌 8.1%。修正很健康，股票不会一直上涨，我个人更倾向于等待再次回到 $100+，而不是 $200+，但鉴于 RDDT 在随机日子有更大的 5-8% 回调，根据历史经验，6-7% 的下跌是日内的好买点，你可能会看到它恢复，但我们可能会看到许多增长股在 11/12 月的大涨前经历更大的修正，所以可能不是真正的底部。 我现在不看图表 RSI，只是基于过去一两年每天观察股票 + IV 的经验感觉来做。 4. AMZN - 没有重大宏观新闻，可能是 10 月 1 日的政府停摆可能会引起指数恐慌，但这没什么大不了的。它下跌了 1.35%，所以我会买入，因为这是摊低成本的好时机。 5. Klarna - $36，下跌 5.3%。有时你只是凭直觉行事。低于 IPO 价格，没有重大新闻。大多数 IPO 都下跌了，比如 Gemini 等。如果你想建立长期头寸，我会在这个水平买入。 6. TSM - $277，我有罪地进行了 $273-$279 之间的波段交易，所以我每次跌至 $273 就买入，在 $277-$279 卖出以获取 2% 的纯股票利润。到目前为止，我用股票做了大约 2 次。如果跌破 $273，我就定投，如果进一步下跌就切换到看涨期权。 没有绝对的对错方式，每个人都有自己的方法。（另外抱歉 CRM，糟糕的财报搞错了那个，如果进一步下跌我可能会摊平成本）。 但一般来说，这只是我浏览每只股票清单时的想法。再次强调，每个人想法不同，我只是想写下我的思考过程，如果对他有帮助的话。
英文原文
Lot of inspirational trader mindsets going around X lately like: "It will pay off. Be Patient". All BS. Traders consider sector momentum, catalysts, valuation, pullbacks, macro, IV, option flows, etc. Here's my mindset for short term trading for various stocks: 1. $NBIS - $111.91, even though it's up 1.53% on the day, CRWV is up 12% off Meta gives them a $14B contract. So usually it's bullish for all neoclouds. It spiked to $117 ( i probably would have still held) but pulled back to $111 likely from too much open interest, but we'll likely keep seeing a rally upward. So I'd use this time to DCA and buy calls/shares even if it's up 1.53% Not "truly a dip" but it's more of a dip during a rally. 2. $HIMS - $56.4 Down 4.67%, usually people just blindly buy the dip but this was actually caused from something material, which was Trump launching a direct to consumer GOV drug website. Short interest decreased back to 33% on the rise to $60. This dip will likely be used for short covering. I did buy $46 support but sold shortly on a bounce after I just felt like it would go down more. But I just personally prefer bottom entry points so that's probably closer to $50. I still remember AMZN launching a competitor, HIMS crashed 20% then rose again, I'd expect the same with Trump's program mid term but near term it's a headwind. 3. $RDDT - $228, down 5.45%, no news. Just probably valuation concerns. We saw similar growth stocks like ALAB, CRED, have random 20% pullbacks. Lot of software/social stocks like SNAP down 8.1% off non-material news. Correction is healthy, stocks don't just keep going up, I'd prefer to wait in the $100+ again, rather than $200+ (just personally), but it's actually a better buy than the rest, given RDDT has larger 5-8% pullbacks on random days, just from historical experiences so 6-7% drop is a good buy intra-day and you'd likely see it recover but we might see a lot of growth stocks have a larger correction into massive rally Nov/Dec so might not be an actual bottom. I don't really look at chart RSI nowadays, just do this based on feelings from experience looking at the stock + IV every day for the past year or two. 4. AMZN - No major macro news, prob government shutdown Oct 1st that might cause some panic for index but it's pretty immaterial. It dropped, 1.35% so I'd buy since it' a good time to cost average. 5. Klarna - $36, 5.3% drop. Sometimes you just go off gut feeling. Below IPO price, no major news. Most IPOs were down like Gemini, etc. If you wanted to build a long term position I'd buy at this level. 6. TSM - $277, I've been guilty of swing trading between $273-$279, so I just buy every drop to $273 and sell at $277-$279 for 2% profit purely with shares. So far I've done this ~2 times with shares. If it drops past $273, I'd just DCA and then if it drops further switch to calls. There's no True or False way to do this, everyone kind of has their own approach. (also sorry about CRM, bad earnings got that one wrong, I'll probably cost avg if ti declines further). But generally this is just what I'm thinking about when I go down the list of every single stock. Once again, everyone thinks differently, I just wanted to write down how I think if it's helpful to others.
-
作者基于英伟达支持、微软大单及宏观降息，将NBIS仓位扩至百万美元，目标价225美元。
关于我将 $NBIS 仓位扩大至 100 万美元以上且目标价定为 225 美元的原因思考： 核心逻辑 ______ 当微软 (MSFT)、谷歌 (GOOGL) 和 Mag7 巨头成为你的客户时（就像 ALAB 或 CRED，我在它们股价低于 100 美元时重仓，或者在 $NVDA、AVGO 或 TSM 起飞之前），公司的未来增长可能会以百分之几百的速度爆发。 历史上几乎没有哪家公司像这样被 Mag7 巨头所依赖。 此外，当英伟达 (NVDA) 也有充分动机推高你的股价时…… NBIS 成为更强的买入标的，是我未来 1 年时间内信心最高的选择。 护城河 + 对英伟达至关重要的 GPU 租赁商 _______ 英伟达看到其他超大规模云厂商如 AMZN、GOOGL 正在构建自己的芯片并减少依赖。 对策？构建 GPU 租赁商（如 CRWV），通过持股和融资，使 Azure/Cloud/AWS 无法取代英伟达。 GPU 的获取越来越多地通过这些租赁商进行，正如我们在 OpenAI 身上看到的，他们不再拥有来自微软的算力，不得不转向谷歌。 谷歌的算力也不够，因此转向 WULF 等公司。微软转向 CRWV、NBIS 等公司，大型科技公司的算力需求向下游这些 GPU 提供商流动。 英伟达有充分理由推高 CoreWeave 和 NBIS 等 GPU 租赁商的估值，以对冲超大规模云厂商自研芯片的风险。 如果没有算力，数十亿美元将流向 NBIS，而英伟达在背后支撑他们。 宏观顺风 _______ Polymarket 已定价 3 次降息。 如果你看过我的另一篇帖子，十年才有一次的三次降息（对流入市场的流动性极其有利）+ 年底季节性因素，这对股票是积极的。 此外，NBIS 市值相对较小，且依赖融资/债务增长。当利息负担下降时，融资成本降低，扩张看起来更可行。 NBIS 的估值 heavily 基于未来收益，随着降息预期，来自微软和其他客户的数十亿美元收入预期将被上调。在昨天的美联储会议后，我们即将看到剧烈的重估。 公司对比 ________ 如果让我选择 NBIS -> CRWV -> WULF -> 其他，权衡潜力与投机性。 CRWV - 英伟达明确支持，市值已达 630 亿美元+。可能涨得更高，但考虑到 NBIS 拥有微软合同、类似的积压订单等，而市值仅为前者的一半多，这就是我选择 NBIS 的原因。 $IREN, BITF, RIOT, $GRRR 等 - 比特币矿工转型算力。我喜欢它们，但它们还没有像微软那样提供去风险化保障。 WULV - 我喜欢它们因为谷歌支持，但 NBIS 的可转债条款和相对于潜力的市值更好。 基本面 ______ 市值：247.8 亿美元（对比 CRWV 的 610 亿美元，后者今年仍下跌 30%），现在拥有类似的收入积压订单，轻松达到相同市值（每股 243 美元+）的潜力很大。 到 2026 年，计入微软交易后，NBIS 总收入可能达到 50-60 亿美元，毛利率强劲（≈70%）。 在 2027-2028 年，如果基础业务（非微软部分）也激进增长，总收入可能达到 80-100 亿美元+。所有这些都伴随着 ~60-75% 的毛利率。 这很疯狂，但主要是因为英伟达支持这些 GPU 公司。基于估值，NBIS 比 CRWV 更具吸引力，且比没有微软背书给予 170 亿美元的 IREN 等其他公司投机性更低。 杂项思考 ___ 他们已经筹集了 41 亿美元+，并为 170 亿美元的微软合同确保了资本支出。这是最大的去风险化事件，也是为什么我在 90 美元+ 投资 NBIS，而不是在 50 美元时投资更投机的标的。 可能还有其他来自超大规模云厂商的合同即将到来。我认为轻松路径是到 140 美元，然后可能因可转债转股下跌，再涨到 200 美元。 可能还有我没提到的细节，如几年后的利润率压缩、运营收入折旧风险等。 但这正是我投资决策的核心（宏观、基本面、行业增长、护城河+激励措施），与波段交易相比，这也是为什么 NBIS 是未来一年高信心标的的原因。
英文原文
Thoughts on why I’m scaling my $NBIS position to $1M+ with a $225 PT: Thesis ______ When MSFT, GOOGL, and Mag7 are your customers like ALAB or CRED (when I took large positions in both sub $100) or before $NVDA or AVGO or TSM took off, a company's forward growth would likely explode in the 100%'s of percent. There are barely any companies in history where Mag7 are dependent on them. On top of that, when NVDA has every incentive to pump your stock as well.... NBIS becomes a stronger buy and has my highest conviction for 1Y timeframe. Moat + GPU lenders Critical Importance to NVDA _______ NVDA sees other hyperscalers like AMZN, GOOGL building out their own chips and reducing reliance. Answer? Build out GPU lenders eg. CRWV, by taking a stake and financing them, so Azure/Cloud/AWS can't replace NVDA. Access to GPUs becomes increasingly through these lenders and as we see with OpenAI, they no longer have the compute from MSFT and have to go to GOOGL. GOOGL also doesn't have enough compute so they go to WULF and others. MSFT goes to CRWV, NBIS and others, and big tech compute flows downstream to these GPU providers. NVIDIA has every reason to inflate GPU lenders like CoreWeave and NBIS to hedge against hyperscaler custom chips. And without compute, billions of dollars will flow to NBIS with NVDA propping them up. Macro Tailwind _______ 3x rate cut priced into Polymarket. If you saw my other post, triple rate cuts only happen once a decade (extremely positive for liquidity flowing into markets) + combined with end of year seasonality, which are positive for equities. On top of that, NBIS is a relatively smaller market cap, and relies on financing/debt to grow. When their interest burden drops, financing gets cheaper, and expansion looks more viable. NBIS is heavily valued on future earnings, and with rate cut projections, far our earnings of billions in rev from MSFT and other clients get marked UP. We're about to see a sharp re-rating after Fed meeting yesterday. Company Comparisons ________ If I had to choose NBIS -> CRWV -> WULF ->others weighing on potential to speculation tradeoffs. CRWV - NVDA clearly backing them, already large $63B+ MC. Could go way higher but growth potential with MSFT contract with NBIS, similar backlog, etc. at more than half the marketcap is why I chose them. $IREN, BITF, RIOT, $GRRR etc. - BTC miners pivoting to compute. I like them but they don't have the same de-risking as MSFT yet. WULF - I do like them since Google is backing them but NBIS conversion terms and MC relative to potential are better. Fundamentals ______ MC: 24.78B (When you compare to CRWV at 61B, which was still down 30% this year), now with similar revenue backlog, it has an easy potential to go to the same marketcap ($243+ a share). By 2026, with Microsoft deal accounted for, NBIS could be doing $5-6B total revenue with strong gross margins (≈70%). In 2027-2028, total revenue could reach $8-10B+, especially if base business (non-Microsoft) also grows aggressively. All with ~60-75% gross margins. This is insane but mainly due to NVDA supporting these GPU companies. Based on valuation, NBIS is more attractive than CRWV and less speculative than IREN or others without MSFT backing giving them 17B. Misc Thoughts ___ They already raised 4.1B+ and secured capex for the $17B MSFT contract. This was the biggest de-risking event and why I'd invest in NBIS at $90+ compared to something more speculative back at $50. There's likely other contracts from hyperscalers coming their way. I'd say easy path to $140, then maybe drop from convertible note, then up to $200. There's probably more specifics that I didn't get to like margin compression in a few years operating income depreciation risk etc. But this was the core of my investment thesis (macro, fundamentals, industry growth, moat + incentives) when I make investment decisions vs. swing trading and why NBIS is high conviction over the next year.